German generic drugmaker Stada (STAGn.DE) said it was holding talks about being taken over with rival suitors Advent International and Cinven Partners.
Stada’s executive board has “started open-minded talks to allow the interested parties to explain their strategic concepts and evaluate further value-enhancing potential with regards to the potential offer price,” it said in a statement on Monday.
Stada earlier said it was weighing two takeover approaches, including one from private equity firm Cinven Partners which valued it at almost 3.5 billion euros ($3.7 billion).
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.